ASCO Guidelines
A podcast by American Society of Clinical Oncology (ASCO)
180 Episoade
-
Endocrine Treatment and Targeted Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Guideline Update
Publicat: 29.07.2021 -
Chemotherapy and Targeted Therapy for Patients with Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor-Negative Guidelin
Publicat: 29.07.2021 -
Telehealth in Oncology: Standards and Practice Recommendations
Publicat: 28.07.2021 -
Salivary Gland Hypofunction and/or Xerostomia Induced by Non-Surgical Cancer Therapies: ISOO/MASCC/ASCO Guideline
Publicat: 20.07.2021 -
Management of the Axilla in Early-Stage Breast Cancer: OH (CCO) and ASCO Guideline
Publicat: 19.07.2021 -
Oncology Medical Home: ASCO and COA Standards
Publicat: 13.07.2021 -
Assessment of Adult Women with Ovarian Masses and Treatment of Epithelial Ovarian Cancer Resource Stratified Guideline
Publicat: 29.06.2021 -
Appropriate Systemic Therapy Dosing for Obese Adult Patients with Cancer Guideline Update
Publicat: 03.05.2021 -
Management of Salivary Gland Malignancy Guideline
Publicat: 26.04.2021 -
Management of Dyspnea in Advanced Cancer Guideline
Publicat: 22.02.2021 -
Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Guideline Update
Publicat: 16.02.2021 -
Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer Guideline
Publicat: 28.01.2021 -
Radiation Therapy for Small Cell Lung Cancer Guideline Endorsement
Publicat: 27.01.2021 -
Initial Management of Non-Castrate Advanced, Recurrent, or Metastatic Prostate Cancer Guideline Update
Publicat: 26.01.2021 -
PREVIEW: ASCO in Action CEO & CMO Interview
Publicat: 19.01.2021 -
Chemotherapy in Combination with Radiotherapy for Definitive-intent Treatment of Stage II to IVA Nasopharyngeal Carcinoma: CSCO-ASCO Guideline
Publicat: 06.01.2021 -
Systemic Therapy for Advanced Hepatocellular Carcinoma Guideline
Publicat: 16.11.2020 -
Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer Guideline Update
Publicat: 20.10.2020 -
Treatment of Metastatic Carcinoma and Myeloma of the Femur: Joint MSTS/ASTRO/ASCO Guideline
Publicat: 01.10.2020 -
PARP Inhibitors in the Management of Ovarian Cancer Guideline
Publicat: 13.08.2020
Explore pivotal recommendations from the latest evidence-based clinical practice guidance with ASCO Guidelines. Join us to discover essential insights and navigate the ever-evolving landscape of cancer research and treatment.
